As Avingtrans Plc (LON:AVG) posts a set of record results, CEO Steve McQuillan outlines a future shaped by soaring demand from nuclear energy, AI data centres and medical innovation. With a £156 million revenue milestone and game-changing contracts from Korea to HS2, Avingtrans is quietly becoming a critical backbone of the global power and infrastructure renaissance. Watch the full interview to hear how the company’s “Pinpoint Invest Exit” strategy could lead to more acquisitions — and even strategic disposals — in the year ahead.
Key Moments:
- 00:23 – FY25 results overview
- 01:05 – Order book strength and visibility
- 01:21 – $16M nuclear contract with KHNP + HS2 win
- 02:18 – Balance sheet and net debt update
- 02:57 – Pinpoint Invest Exit strategy explained
- 03:08 – Revenue growth drivers and new nuclear
- 04:46 – Medical division update: Magnetica & Adaptex progress
- 06:03 – How AI and data centres are fuelling demand
- 08:13 – What’s next: organic growth, acquisitions, and potential disposals
Avingtrans Plc designs, manufactures and supplies critical components, modules and systems for the energy, medical and industrial sectors.
